ELVN filings
Corporate insider profile
Benjamin Hohl Filing Activity
Latest reported as CHIEF FINANCIAL OFFICER of Enliven Therapeutics, Inc. (ELVN).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$263,577.57
- Latest transaction
- Jun 17, 2026
Affiliated corporations
Reported company relationships
Transaction history
